Immunotherapy treatments for cancer have been found to cause common skin-related toxicities. The treatments, which include immune checkpoint inhibitors such as PD-1/PD-L1 inhibitors, can have significant effects on the body. Research on these treatments is ongoing, with some studies examining their use in combination with chemotherapy for certain types of cancer, and others exploring their potential to eliminate cancer throughout the body.